CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Mabwell Shanghai Bioscience Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Mabwell Shanghai Bioscience Co Ltd
4th Floor, Building 3
No 576 (Chuangxiang Garden)
Phone: +86 2158332260p:+86 2158332260 SHANGHAI, SHA  201210  China Ticker: 688062688062

Business Summary
Mabwell Shanghai Bioscience Co Ltd is a China-based company mainly engaged in the research and development, production and sales of therapeutic biological products. The Company's main businesses include the establishment of new varieties of drugs and the discovery of some early projects, the organization and development of preclinical research and pharmacological effects, and the development of drugs for preclinical research. The Company is also engaged in the organization, management and development of clinical trials of research species. The Company's research on drugs covers autoimmune, tumor, metabolism, ophthalmology, infection and other disease fields. The Company conducts business in domestic and foreign markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board ChunshanTang 54 6/21/2020 6/21/2020
Finance Director YinYe 6/21/2020 6/21/2020
Chief Scientific Officer XinDu
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,052 (As of 12/31/2022)
Outstanding Shares: 399,600,000 (As of 1/18/2024)
Shareholders: 32,349
Stock Exchange: SHA
Fax Number: +86 2158585793
Email Address: contact@mabwell.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, March 28, 2024